Sewoon Medical Co., Ltd (KOSDAQ:100700)
2,705.00
+85.00 (3.24%)
At close: Apr 2, 2026
Sewoon Medical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 97,024 | 86,098 | 75,710 | 32,003 | 44,852 |
Short-Term Investments | - | - | - | 25,000 | 7,000 |
Cash & Short-Term Investments | 97,024 | 86,098 | 75,710 | 57,003 | 51,852 |
Cash Growth | 12.69% | 13.72% | 32.82% | 9.93% | 49.59% |
Accounts Receivable | 13,088 | 12,544 | 12,790 | 13,220 | 12,043 |
Other Receivables | 152.38 | 232.88 | 132.41 | 175.85 | 75.73 |
Receivables | 13,241 | 12,777 | 12,922 | 13,396 | 12,118 |
Inventory | 16,976 | 19,224 | 17,492 | 18,211 | 16,839 |
Prepaid Expenses | 136.82 | 78.5 | 63.94 | 67.25 | 50.69 |
Other Current Assets | 1,777 | 1,203 | 1,741 | 2,911 | 1,958 |
Total Current Assets | 129,155 | 119,381 | 107,929 | 91,588 | 82,819 |
Property, Plant & Equipment | 31,937 | 34,328 | 35,571 | 37,884 | 38,184 |
Long-Term Investments | 16.39 | 16.39 | 104.19 | 92.73 | 69.13 |
Other Intangible Assets | 925.72 | 1,266 | 919.79 | 1,171 | 1,530 |
Long-Term Accounts Receivable | 0 | 0 | -0 | -0 | - |
Long-Term Deferred Tax Assets | 659.45 | 620.1 | 698.28 | 415.01 | 738.43 |
Long-Term Deferred Charges | - | - | 22.59 | 45.17 | 67.76 |
Other Long-Term Assets | 1,179 | 1,237 | 1,367 | 1,282 | 1,317 |
Total Assets | 163,872 | 156,848 | 146,612 | 132,479 | 124,725 |
Accounts Payable | 1,360 | 1,107 | 1,183 | 1,249 | 1,290 |
Current Portion of Leases | 151.64 | 281.36 | 160.04 | 285.18 | 165.89 |
Current Income Taxes Payable | 1,836 | 912.61 | 2,638 | 898.41 | 3,144 |
Other Current Liabilities | 5,511 | 4,709 | 4,316 | 4,264 | 3,559 |
Total Current Liabilities | 8,858 | 7,010 | 8,297 | 6,697 | 8,160 |
Long-Term Leases | 612.16 | 772.04 | 621.62 | 757.5 | 644.2 |
Other Long-Term Liabilities | -0 | 0 | 0 | -0 | -0 |
Total Liabilities | 9,471 | 7,782 | 8,919 | 7,455 | 8,804 |
Common Stock | 4,380 | 4,380 | 4,380 | 4,380 | 4,380 |
Additional Paid-In Capital | 3,289 | 3,289 | 3,289 | 3,289 | 3,289 |
Retained Earnings | 145,976 | 136,661 | 127,529 | 115,169 | 106,927 |
Treasury Stock | -4,033 | -1,046 | -1,046 | -1,046 | -1,046 |
Comprehensive Income & Other | 1,560 | 2,833 | 1,005 | 1,212 | 583.92 |
Total Common Equity | 151,172 | 146,118 | 135,157 | 123,005 | 114,135 |
Minority Interest | 3,229 | 2,948 | 2,536 | 2,019 | 1,786 |
Shareholders' Equity | 154,401 | 149,066 | 137,693 | 125,024 | 115,921 |
Total Liabilities & Equity | 163,872 | 156,848 | 146,612 | 132,479 | 124,725 |
Total Debt | 763.8 | 1,053 | 781.66 | 1,043 | 810.09 |
Net Cash (Debt) | 96,260 | 85,045 | 74,929 | 55,961 | 51,042 |
Net Cash Growth | 13.19% | 13.50% | 33.89% | 9.64% | 51.57% |
Net Cash Per Share | 2254.54 | 1964.85 | 1730.81 | 1292.66 | 1179.04 |
Filing Date Shares Outstanding | 41.87 | 43.29 | 43.29 | 43.29 | 43.29 |
Total Common Shares Outstanding | 41.87 | 43.29 | 43.29 | 43.29 | 43.29 |
Working Capital | 120,296 | 112,371 | 99,632 | 84,891 | 74,659 |
Book Value Per Share | 3610.85 | 3375.24 | 3122.05 | 2841.35 | 2636.45 |
Tangible Book Value | 150,246 | 144,851 | 134,237 | 121,834 | 112,605 |
Tangible Book Value Per Share | 3588.74 | 3345.99 | 3100.80 | 2814.30 | 2601.12 |
Land | 7,859 | 7,859 | 7,524 | 7,524 | 7,498 |
Buildings | 24,841 | 25,436 | 25,064 | 25,171 | 22,439 |
Machinery | 34,419 | 35,090 | 33,652 | 32,883 | 31,885 |
Construction In Progress | 594.4 | 247.6 | 597.63 | 605.02 | 1,747 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.